An Exploratory Phase IIa Study to Investigate the Biological Activity of Oral FX125L in Adult Patients with Mild to Moderate Asthma
Latest Information Update: 05 May 2015
At a glance
- Drugs FX 125L (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors STX Pharma
- 02 May 2015 Status changed from recruiting to completed as reported by EU Clinical Trials Register record.
- 30 Oct 2014 New trial record